Company Overview

Nidan Laboratories & Healthcare Limited, originally incorporated as Abhi Diagnostic Imagings Private Limited in 2000, is a prominent player in the diagnostic healthcare segment. Operating as part of the larger Nidan Group ecosystem, the company specializes in providing a wide array of diagnostic services.

Business Operations and Services

The company is primarily engaged in offering diagnostic services, including radiology, neurology, cardiology, dental, and pathology services. It operates an extensive network of 35 diagnostic centers across Greater Mumbai under the Nidan Diagnostics brand.

Nidan Diagnostics provides a comprehensive suite of medical diagnostic services designed to meet diverse healthcare needs:

- Pathology Tests: Ranging from basic biochemistry and clinical pathology to advanced cytogenetic and molecular diagnostic tests.

- Radiology Tests: Including basic echocardiograms, X-Rays, and ultrasounds, as well as advanced imaging such as CT scans and MRI scans.

- Value-Added Services: The company also offers customized health and wellness packages, home collection of specimens, house calls, and flexible delivery/access modes for test reports, emphasizing a customer-centric approach.

Target Demographics and Service Range

Nidan Healthcare's diagnostic tests cater to a broad spectrum of age groups, offering services for prenatal screening, hormonal imbalance assessment, nutritional deficiency checks, and monitoring lifestyle disorders. This comprehensive approach ensures Nidan Healthcare serves patients across various life stages and health conditions, positioning it as a convenient destination for diagnostic needs.

Stock Exchange Listing and Market Performance

Nidan Laboratories and Healthcare Limited is listed on both major Indian stock exchanges:

- BSE Code: _(Not specified)_

- NSE Symbol: NIDAN

- ISIN: INE0J6L01013

The company trades under the symbol NIDAN on the National Stock Exchange (NSE) and is classified within the Healthcare sector.

As of recent market data, Nidan Laboratories & Healthcare Ltd has an approximate market capitalization of ₹26 Crore. Share price data indicates a 52-week high of ₹41.15 and a 52-week low of ₹16.25.

Financial Performance and Key Metrics

The company's financial performance indicates some operational challenges along with areas of improvement:

- Operating Revenue: Rs. 70.80 Cr (Trailing 12 Months)

- Revenue Growth: Annual revenue de-growth of -2%

- Profitability: Pre-tax margin of -10%; ROE of -4%

- Debt Management: A reasonable debt-to-equity ratio of 6%, indicating a healthy balance sheet.

- Recent FY25 Results: Audited results for FY25 show a net profit of Rs. 197.69 Lacs for the year ended March 31, 2025.

Operational Efficiency Improvements:

- Debtor Days: Improved from 39.1 to 18.9 days, signaling enhanced collection processes and cash flow management.

Growth Trajectory and Market Position

The company has demonstrated:

- Sales Growth: A modest sales growth of 2.76% over the past five years, suggesting scope for scaling operations and market expansion.

- Return on Equity: A low ROE of 2.61% over the last 3 years, indicating potential for improved shareholder returns.

Despite these challenges, Nidan Laboratories & Healthcare Limited maintains a presence in the essential diagnostic services sector. The diagnostic industry has experienced heightened demand, especially post-COVID-19, driven by increased consumer focus on preventive healthcare and early diagnosis.

Corporate Governance and Management

The company's management team includes key individuals such as Abhijeet Dhanegaonkar, Akshay Joshi, Krupesh Deepak Thakur, Tejal Anil Jayakar, Edwin Francis Dabre, Nilesh Ghanshyam Bide, and Abhinay Shashikant Nerurkar.

Key Governance Aspects:

- Promoter Holding: 57.0%, indicating significant promoter stake and alignment with company performance.

- Stakeholder Communication: Regular disclosures to stock exchanges regarding board meetings, financial results, and corporate actions.

- Auditors: The company has recently appointed new auditors to ensure continued high standards of governance and compliance.